1075eur
3,4 %
Date:2025-06-24Time:16:56:10Latest report:Q4-2024List:First NorthTicker:NXTMH
Market Cap:79 meurEnterprise Value:81 meurNet Sales:8,74 meurEarnings:-0,89 meurEmployees:0ISIN:FI4000506811

Ratios

10-year key figure history for Nexstim turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Nexstim with index and moving average MA50 and MA200.

Stockprice:10,75
MA50:8,36
MA200:7,06
Price/MA200:55,9 %
RSI (14):84,8
Price/MA50:31,6 %

Description

Nexstim operates in medical technology. The company has developed a non-invasive brain stimulation technology called SmartFocus®. It is a navigated transcranial magnetic stimulation (nTMS) technology with 3D navigation providing targeting of the TMS to the specific area of the brain. The technology is aimed for the treatment of major depression and chronic neuropathic pain. The company was founded in 2000 and has its headquarters in Helsinki.

Medical Equipment